NCT07092904View on ClinicalTrials.gov

Myocardial Infarction Safe Emergency Medicine Accompanying Study: Providing Reperfusion Therapy Within the Recommended Time Limits

Not yet recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

March 1, 2026

Study Completion Date

April 30, 2026

Conditions

Infarction

Trial Locations (1)

Unknown

University hospital North Norway, Tromsø

All Listed Sponsors

lead

University Hospital of North Norway

OTHER

NCT07092904 - Myocardial Infarction Safe Emergency Medicine Accompanying Study: Providing Reperfusion Therapy Within the Recommended Time Limits | Biotech Hunter | Biotech Hunter